Tuấn NA, Hoà NTT, Quảng LV, Thanh VH. First – line Afatinib treatment outcomes in stage IV non – small cell lung cancer harboring uncommon EGFR mutations at Vietnam National Cancer Hospital. TCNCYH [Internet]. 2026Aug.4 [cited 2026Nov.8];204(7):448-5. Available from: https://tapchinghiencuuyhoc.vn/index.php/tcncyh/article/view/5438